Position in ABBV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$6,234,129
+$685,960 QoQ
Shares Held
24,774
-2.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
#1,181
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026New England Research & Management, Inc. holds $31,997,185 across 8 Drug Manufacturers - General names. ABBV ranks #2 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,527 | $7,498,972 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
24,774 | $6,234,129 | |
| 3 | AMGN |
Amgen Inc
|
11,880 | $4,301,985 | |
| 4 | LLY |
ELI LILLY & Co
|
3,556 | $4,265,173 | |
| 5 | MRK |
Merck & Co., Inc.
|
27,279 | $3,505,351 | |
| 6 | AZN |
Astrazeneca PLC
|
15,893 | $3,013,630 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
21,070 | $2,661,983 | |
| 8 | PFE |
Pfizer Inc
|
21,427 | $515,962 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,234,129 | 24,774 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $5,548,169 | 25,510 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,931,042 | 21,581 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $4,584,723 | 19,801 | Shares | Sole | 2025-10-06 | |
| 2025-06-30 | $3,794,258 | 20,441 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $4,003,089 | 19,106 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,797,804 | 21,372 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,585,408 | 13,092 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $1,968,363 | 11,476 | Shares | Sole | 2024-07-09 | |
| 2024-03-31 | $922,882 | 5,068 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $779,034 | 5,027 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $834,736 | 5,600 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $799,353 | 5,933 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $949,048 | 5,955 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $978,548 | 6,055 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $1,225,337 | 9,130 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $923,554 | 6,030 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $977,523 | 6,030 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $2,120,093 | 15,658 | Shares | Sole | 2022-01-05 | |
| 2021-09-30 | $1,689,028 | 15,658 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $1,772,165 | 15,733 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $1,708,036 | 15,783 | Shares | Sole | 2021-04-16 | |
| 2020-12-31 | $1,684,398 | 15,720 | Shares | Sole | 2021-01-07 | |
| 2020-09-30 | $1,280,565 | 14,620 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $1,443,736 | 14,705 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $758,471 | 9,955 | Shares | Sole | 2020-06-15 | |
| No filing history on record for this holder in this stock. | ||||||